These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7605704

  • 1. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM, Farina C, Airaghi R, Allievi E, Banfi S, Bertolini D, Ferni G, Frattola D, Oneta S, Pinza M.
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [Abstract] [Full Text] [Related]

  • 2. Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actions.
    Uda K, Kobayashi Y, Hisada T, Orlowski RC, Bastian JW, Arnaud CD, Wakabayashi K.
    Biol Pharm Bull; 1999 Mar; 22(3):244-52. PubMed ID: 10220278
    [Abstract] [Full Text] [Related]

  • 3. Biological properties of salmon calcitonin IV.
    Schecroun N, Pidoux E, Horne WC, Hernandez-Lagunas L, Baron R, Cressent M.
    J Bone Miner Res; 1999 Aug; 14(8):1425-31. PubMed ID: 10457276
    [Abstract] [Full Text] [Related]

  • 4. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW, Jin QK, Sbacchi M, Wang L, Belfiore P, Garnier M, Kazantzis A, Kapurniotu A, Zaratin PF, Scheideler MA.
    J Med Chem; 2002 Feb 28; 45(5):1108-21. PubMed ID: 11855991
    [Abstract] [Full Text] [Related]

  • 5. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
    Yates AJ, Gutierrez GE, Garrett IR, Mencel JJ, Nuss GW, Schreiber AB, Mundy GR.
    Endocrinology; 1990 Jun 28; 126(6):2845-9. PubMed ID: 2351097
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.
    Arnett TR, Dempster DW.
    Endocrinology; 1987 Feb 28; 120(2):602-8. PubMed ID: 3467966
    [Abstract] [Full Text] [Related]

  • 7. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
    Lee KC, Park MO, Na DH, Youn YS, Lee SD, Yoo SD, Lee HS, DeLuca PP.
    Calcif Tissue Int; 2003 Dec 28; 73(6):545-9. PubMed ID: 14508623
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of salmon calcitonin on bone resorption: morphological study of the tibial growth plate in rats.
    Pazzaglia UE, Zatti G, Di Nucci A, Coci A.
    Calcif Tissue Int; 1993 Feb 28; 52(2):125-9. PubMed ID: 8443688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits.
    Reginster JY, Azria M, Gaspar S, Bleicher M, Franchimont N, Behhar M, Albert A, Franchimont P.
    Calcif Tissue Int; 1992 Jun 28; 50(6):518-20. PubMed ID: 1525707
    [Abstract] [Full Text] [Related]

  • 13. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, Lechowska BA, Hoffman SJ, Smith BR, Kapadia R, Liang X, Erhard K, Ru Y, Dong X, Marquis RW, Veber D, Gowen M.
    Bone; 2002 May 28; 30(5):746-53. PubMed ID: 11996914
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Profile of a new calcitonin: carbocalcitonin-(Asu1,7) E-CT].
    Nogarin L, Passarella E.
    Minerva Med; 1984 Jul 31; 75(30-31):1809-18. PubMed ID: 6207466
    [Abstract] [Full Text] [Related]

  • 18. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
    Fenton AJ, Martin TJ, Nicholson GC.
    J Cell Physiol; 1993 Apr 31; 155(1):1-7. PubMed ID: 8468357
    [Abstract] [Full Text] [Related]

  • 19. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin.
    Watanabe Y, Mizufune Y, Kubomura A, Kiriyama M, Utoguchi N, Matsumoto M.
    Biol Pharm Bull; 1998 Nov 31; 21(11):1187-90. PubMed ID: 9853410
    [Abstract] [Full Text] [Related]

  • 20. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.
    Dani BA, Raiche AT, Puleo DA, DeLuca PP.
    AAPS PharmSciTech; 2002 Nov 31; 3(3):E21. PubMed ID: 12916936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.